Mesoblast reveals more COVID trials needed, shares tumble

Mesoblast reveals more COVID trials needed, shares tumble

Sydney Morning Herald

Published

The Melbourne biotech has been advised by the US medicines regulator that it will need to run another trial of its COVID-19 treatment before it can apply for emergency approvals.

Full Article